Product Code: GVR-4-68040-187-7
Nuclear Imaging Equipment Market Growth & Trends:
The global nuclear imaging equipment market is anticipated to reach USD 7.91 billion by 2030, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 3.14% during the forecast period. The primary factor contributing to the market is the increasing prevalence of chronic diseases and the growing demand for accurate and early diagnostic techniques. Nuclear imaging devices play a pivotal role in the diagnosis of conditions such as cancer, cardiovascular diseases, and neurological disorders, contributing to the expanding applications of these technologies in clinical settings.
Numerous technological advancements and ongoing research and development activities also play a pivotal role in driving market growth. A notable example is the introduction of hybrid imaging systems that integrate nuclear imaging with other modalities such as computed tomography (CT) and magnetic resonance imaging (MRI). These integrated solutions provide comprehensive diagnostic information, giving more efficient and precise patient assessments. For instance, as reported in an article by Siemens Healthcare in April 2023, doctors in Brazil and Argentina discovered that upgrading their PET/CT scanners not only enabled them to effectively address new patient demands and alleviate scheduling pressures but also surpassed expectations by creating opportunities to explore new areas of care.
Moreover, the aging population is a significant factor contributing to the growing demand for nuclear imaging in healthcare. As the elderly population is more prone to various health issues, there is an increase in the requirement for accurate diagnostic tools capable of aiding in the early detection and monitoring of age-related diseases.For instance, according to the World Health Organization (WHO), it is projected that by the year 2030, one in six people worldwide will be aged 60 years or over. This demographic shift emphasizes the increasing prevalence of an aging population and underscores the importance of advanced diagnostic tools, such as nuclear imaging, in addressing the healthcare needs of this demographic group.
Nuclear Imaging Equipment Market Report Highlights:
- On the basis of modality, SPECT segment dominated the market in 2023 by capturing a share of 58.86%
- On the basis of application, the oncology segment dominated the market with a share of 49.21%.
- The cardiology segment is expected to grow at the fastest rate over the forecast period
- Among end-use, hospitals held a majority share of the market of 52.75% in the year 2023. As hospitals are adopting nuclear imaging equipment at an increasing rate
- North America dominated the market with a share of 42.00% in 2023. The market is competitive, with both established companies and emerging players striving to capture market share through product innovation, mergers, acquisitions, and partnerships. Thus, the presence of the key players in this region enhances the industry's growth
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Modality
- 1.2.2. Application
- 1.2.3. End-use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Modality outlook
- 2.2.2. Application Outlook
- 2.2.3. End-use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Nuclear Imaging Equipment Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Growing prevalence of cancer
- 3.2.1.2. Technological advancements
- 3.2.1.3. Increasing awareness of diagnostic needs
- 3.2.2. Market restraint analysis
- 3.2.2.1. Stringent regulatory framework
- 3.2.2.2. High cost of procedures
- 3.3. Nuclear Imaging Equipment Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Nuclear Imaging Equipment Market: Modality Estimates & Trend Analysis
- 4.1. Modality Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. Global Nuclear Imaging Equipment Market by Modality Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.4.1. SPECT
- 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. PET
- 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Nuclear Imaging Equipment Market: Application Estimates & Trend Analysis
- 5.1. Application Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. Global Nuclear Imaging Equipment Market by Application Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.4.1. Cardiology
- 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Oncology
- 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Neurology
- 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Others
- 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Nuclear Imaging Equipment Market: End-use Estimates & Trend Analysis
- 6.1. End-use Market Share, 2023 & 2030
- 6.2. Segment Dashboard
- 6.3. Global Nuclear Imaging Equipment Market by End-use Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.4.1. Hospitals
- 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
- 6.4.2. Imaging Centers
- 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. R&D
- 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.4. Others
- 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Nuclear Imaging Equipment Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.5. North America
- 7.5.1. North America Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. U.S.
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Reimbursement Scenario
- 7.5.2.5. U.S. Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Canada
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Reimbursement Scenario
- 7.5.3.5. Canada Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Europe
- 7.6.1. Europe Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. UK
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Reimbursement Scenario
- 7.6.2.5. UK Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Germany
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Reimbursement Scenario
- 7.6.3.5. Germany Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. France
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. Reimbursement Scenario
- 7.6.4.5. France Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Italy
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Reimbursement Scenario
- 7.6.5.5. Italy Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.6. Spain
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Competitive Scenario
- 7.6.6.3. Regulatory Framework
- 7.6.6.4. Reimbursement Scenario
- 7.6.6.5. Spain Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.7. Denmark
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Competitive Scenario
- 7.6.7.3. Regulatory Framework
- 7.6.7.4. Reimbursement Scenario
- 7.6.7.5. Denmark Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.8. Sweden
- 7.6.8.1. Key Country Dynamics
- 7.6.8.2. Competitive Scenario
- 7.6.8.3. Regulatory Framework
- 7.6.8.4. Reimbursement Scenario
- 7.6.8.5. Sweden Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.9. Norway
- 7.6.9.1. Key Country Dynamics
- 7.6.9.2. Competitive Scenario
- 7.6.9.3. Regulatory Framework
- 7.6.9.4. Reimbursement Scenario
- 7.6.9.5. Norway Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7. Asia Pacific
- 7.7.1. Asia Pacific Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.2. Japan
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Competitive Scenario
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. Reimbursement Scenario
- 7.7.2.5. Japan Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.3. China
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Competitive Scenario
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Reimbursement Scenario
- 7.7.3.5. China Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.4. India
- 7.7.4.1. Key Country Dynamics
- 7.7.4.2. Competitive Scenario
- 7.7.4.3. Regulatory Framework
- 7.7.4.4. Reimbursement Scenario
- 7.7.4.5. India Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. Key Country Dynamics
- 7.7.5.2. Competitive Scenario
- 7.7.5.3. Regulatory Framework
- 7.7.5.4. Reimbursement Scenario
- 7.7.5.5. South Korea Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.6. Australia
- 7.7.6.1. Key Country Dynamics
- 7.7.6.2. Competitive Scenario
- 7.7.6.3. Regulatory Framework
- 7.7.6.4. Reimbursement Scenario
- 7.7.6.5. Australia Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.7.7. Thailand
- 7.7.7.1. Key Country Dynamics
- 7.7.7.2. Competitive Scenario
- 7.7.7.3. Regulatory Framework
- 7.7.7.4. Reimbursement Scenario
- 7.7.7.5. Thailand Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8. Latin America
- 7.8.1. Latin America Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.2. Brazil
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Competitive Scenario
- 7.8.2.3. Regulatory Framework
- 7.8.2.4. Reimbursement Scenario
- 7.8.2.5. Brazil Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.3. Mexico
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Competitive Scenario
- 7.8.3.3. Regulatory Framework
- 7.8.3.4. Reimbursement Scenario
- 7.8.3.5. Mexico Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.8.4. Argentina
- 7.8.4.1. Key Country Dynamics
- 7.8.4.2. Competitive Scenario
- 7.8.4.3. Regulatory Framework
- 7.8.4.4. Reimbursement Scenario
- 7.8.4.5. Argentina Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9. Middle East & Africa
- 7.9.1. Middle East & Africa Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.2. South Africa
- 7.9.2.1. Key Country Dynamics
- 7.9.2.2. Competitive Scenario
- 7.9.2.3. Regulatory Framework
- 7.9.2.4. Reimbursement Scenario
- 7.9.2.5. South Africa Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.3. Saudi Arabia
- 7.9.3.1. Key Country Dynamics
- 7.9.3.2. Competitive Scenario
- 7.9.3.3. Regulatory Framework
- 7.9.3.4. Reimbursement Scenario
- 7.9.3.5. Egypt Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.4. UAE
- 7.9.4.1. Key Country Dynamics
- 7.9.4.2. Competitive Scenario
- 7.9.4.3. Regulatory Framework
- 7.9.4.4. Reimbursement Scenario
- 7.9.4.5. UAE Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.9.5. Kuwait
- 7.9.5.1. Key Country Dynamics
- 7.9.5.2. Competitive Scenario
- 7.9.5.3. Regulatory Framework
- 7.9.5.4. Reimbursement Scenario
- 7.9.5.5. Kuwait Nuclear Imaging Equipment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. Key customers
- 8.3.2. Key company market share analysis, 2023
- 8.3.3. GE HealthCare
- 8.3.3.1. Company overview
- 8.3.3.2. Financial performance
- 8.3.3.3. Product benchmarking
- 8.3.3.4. Strategic initiatives
- 8.3.4. Siemens Healthineers
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Koninklijke Philips N.V.
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Mediso
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Canon Medical Systems Corporation
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Cubresa Inc.
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Shimadzu Corporation
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. United Imaging Healthcare Co
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives